返回 Agendas
A Biopharmaceutical Company/Services Provider Partnership: Value to Both Companies and Progress to Date
Session Chair(s)
Stacie Yonkin
Covance, United States
This session will focus on the rationale and benefits of establishing a sole source partnership between two companies that are leaders in the clinical development space and possess complementary areas of expertise and company culture.
Learning Objective : Describe the rationale behind the partnership between a biopharmaceutical company and a contract research organization (CRO); Discuss implementation of best practices in clinical development; Examine early successes and lessons learned; Explain the potential of this partnership model for other biopharmaceutical companies and CROs.
Speaker(s)
CRO Perspective
Stacie Yonkin
Covance, United States
Pharma Perspective
Frances Grote, MBA
Biogen Inc., United States
Senior Director, Clinical Operations Vendor Oversight
注册方法
Registration override should work.